These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19834276)

  • 1. Refractory plasmablastic type myeloma with multiple extramedullary plasmacytomas and massive myelomatous effusion: remarkable response with a combination of thalidomide and dexamethasone.
    Nakazato T; Suzuki K; Mihara A; Sanada Y; Kakimoto T
    Intern Med; 2009; 48(20):1827-32. PubMed ID: 19834276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of extramedullary plasmablastic plasmacytoma successfully treated using a combination of thalidomide and dexamethasone and a review of the medical literature.
    Sekiguchi Y; Asahina T; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Komatsu N; Noguchi M
    J Clin Exp Hematop; 2013; 53(1):21-8. PubMed ID: 23801130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelomatous pleural effusion.
    Ghosh S; Gopal R; Advani SH
    J Assoc Physicians India; 2006 Sep; 54():738-9. PubMed ID: 17212026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
    Jiménez-Segura R; Granell M; Gironella M; Abella E; García-Guiñón A; Oriol A; Cabezudo E; Clapés V; Soler JA; Escoda L; López-Pardo J; Fernández de Larrea C; Cibeira MT; Tovar N; Isola I; Bladé J; Rosiñol L;
    Eur J Haematol; 2019 May; 102(5):389-394. PubMed ID: 30719772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral melphalan, dexamethasone, and thalidomide for the treatment of refractory multiple myeloma.
    Asou N; Izuno Y; Okubo T; Ide K; Ueno H; Kawakita M; Mitsuya H; Hata H
    Int J Hematol; 2007 Jul; 86(1):69-71. PubMed ID: 17675270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical analysis of 25 cases of multiple myeloma complicated by extramedullary plasmacytomas].
    Zhong YP; Chen SL
    Zhonghua Nei Ke Za Zhi; 2009 May; 48(5):396-8. PubMed ID: 19615158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid response of plasmacytomas to lenalidomide plus low-dose dexamethasone therapy in a patient with relapsed multiple myeloma.
    Fukushima T; Nakamura T; Iwao H; Umehara H
    Am J Hematol; 2011 Oct; 86(10):893. PubMed ID: 21812018
    [No Abstract]   [Full Text] [Related]  

  • 8. Response of the extramedullary lung plasmacytoma with pleural effusion to chemotherapy.
    Nagai K; Ando K; Yoshida H; Kusaka S; Hinuma Y; Hakamata Y; Ishii K; Kume N; Ochi H; Wakatsuki Y; Yokode M; Murakami M; Kita T
    Ann Hematol; 1997 Jun; 74(6):279-81. PubMed ID: 9236513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma.
    Dytfeld D; Matuszak M; Lewandowski K; Komarnicki M
    Ann Hematol; 2008 Mar; 87(3):253-4. PubMed ID: 17955241
    [No Abstract]   [Full Text] [Related]  

  • 10. IgG myeloma presenting as a large mediastinal mass and pleural effusion.
    Raci-Wetherbee E; Dincer HE
    J Bronchology Interv Pulmonol; 2012 Jan; 19(1):65-7. PubMed ID: 23207268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib in relapsed multiple myeloma complicated by extramedullary plasmacytomas.
    Hughes M; Micallef-Eynaud P
    Clin Lab Haematol; 2006 Aug; 28(4):267-9. PubMed ID: 16898968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma.
    García-Sanz R; González-Porras JR; Hernández JM; Polo-Zarzuela M; Sureda A; Barrenetxea C; Palomera L; López R; Grande-García C; Alegre A; Vargas-Pabón M; Gutiérrez ON; Rodríguez JA; San Miguel JF
    Leukemia; 2004 Apr; 18(4):856-63. PubMed ID: 14973508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solitary bone plasmacytoma terminally developed myeloma with multiple extramedullary lesions and myelomatous pleural effusion and ascites.
    Matsumoto A; Nagata K; Hamaguchi H; Taki K
    Int J Hematol; 1993 Dec; 59(1):59-65. PubMed ID: 8161736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelomatous pleural effusion in multiple myeloma- A rare presentation.
    Pradeep IY; Mayuri RK; Sourabh SP; Nirali MP
    J Cancer Res Ther; 2024 Jan; 20(1):476-478. PubMed ID: 38554369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant myelomatous pleural effusion with good response to combination chemotherapy.
    Attili VS; Singh VP; Sundar S; Mehta H; Negi ML; Gogia A; Raju SH; Rai M
    J Assoc Physicians India; 2007 Aug; 55():595-6. PubMed ID: 18019805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose thalidomide in patients with relapsed or refractory multiple myeloma.
    Kees M; Dimou G; Sillaber C; Drach J; Ackermann J; Lechner K; Gisslinger H
    Leuk Lymphoma; 2003 Nov; 44(11):1943-6. PubMed ID: 14738147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of relapsed multiple myeloma complicated by cardiac extramedullary plasmacytoma with D-PACE chemotherapy.
    Toocheck C; Pinkhas D
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29523615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of permanent indwelling catheter for long-term administration of intrapleural chemotherapy.
    Lázaro Sierra J; Carrasco V; Cases E; Gómez Gonzalez C
    Arch Bronconeumol; 2017 Oct; 53(10):590-591. PubMed ID: 28359605
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
    Katodritou E; Terpos E; Symeonidis AS; Pouli A; Kelaidi C; Kyrtsonis MC; Kotsopoulou M; Delimpasi S; Christoforidou A; Giannakoulas N; Viniou NA; Stefanoudaki E; Hadjiaggelidou C; Christoulas D; Verrou E; Gastari V; Papadaki S; Polychronidou G; Papadopoulou A; Giannopoulou E; Kastritis E; Kouraklis A; Konstantinidou P; Anagnostopoulos A; Zervas K; Dimopoulos MA
    Am J Hematol; 2014 Aug; 89(8):803-8. PubMed ID: 24757085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of extramedullary plasmacytoma of the cavernous sinus using a combination of intermediate dose of thalidomide and dexamethasone.
    Katodritou E; Speletas M; Pouli A; Tsitouridis J; Zervas K; Terpos E
    Acta Haematol; 2007; 117(1):20-3. PubMed ID: 17106187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.